Nurix Therapeutics, Inc.

Clinical-stage biopharmaceutical company focused on targeted protein degradation therapies for cancer and autoimmune diseases, including bexobrutideg (NX-5948).

To provide comprehensive coverage, we aggregate data and news under the name Nurix, encompassing the following company names, divisions, and related entities:

Nurix Inc. and Kura Therapeutics, Inc..

This list encompasses current and former names, alternate names, and key divisions associated with Nurix, ensuring you can easily find all relevant information under a single, unified profile.